FREQUENTLY Asked Questions

MedsDirectRx is a pharmacy benefit solution that helps reduce prescription drug costs by sourcing medications globally. The program focuses on high-cost prescriptions, ensuring savings while maintaining safety, regulatory compliance, and convenience for both employers and employees.

The MedsDirectRx Program is designed to minimize disruption. It specifically targets the 3% of employees who account for 50% of your prescription drug costs. By focusing on this small group, the program delivers significant savings while keeping the impact on the broader workforce very limited.

Simply complete the Contact Us form on this website. A sales representative will reach out to you within 24 hours. From onboarding to the first prescription delivery, the process typically takes about 30 days.

Self-funded employers typically reduce their overall pharmacy spend by around 25%, which equals about $600 per employee per year. For certain high-cost medications, savings can be even greater-up to 75% compared to traditional pricing.

MedsDirectRx brings you the best of both worlds! We source medications from trusted, regulated pharmacies in top-tier countries like Canada, the UK, and across the EU. We also offer FDA-approved medications made right here in the U.S.— ensuring your company gets safe, high-quality medications at the best possible price.

MedsDirectRx operates within the FDA’s Personal Importation Policy (PIP) by: Sourcing medications only from Tier 1 countries with strict pharmaceutical standards. Ensuring all prescriptions are for personal use only, not resale. Requiring valid prescriptions from licensed U.S. providers. Limiting shipments to a 90-day supply per medication. Avoiding any drugs that are considered health risks or not permitted under FDA guidelines.

Personal importation refers to an individual purchasing or bringing prescription medications from another country for their own personal use, not for resale. The FDA allows personal importation under its enforcement discretion policy, commonly known as the Personal Importation Policy (PIP). Under this policy, individuals may import a small quantity of medication (typically up to a 90-day supply) if: The medication is for a serious condition. It is not considered a health risk. It is for personal use only, not resale.

Yes. Most brand-name drugs sold in the U.S. are manufactured in the same overseas facilities that also supply Tier-1 markets such as Canada, the UK, and the EU. MedsDirectRx sources exclusively from these Tier-1 countries, ensuring equivalence in quality, safety, and efficacy. While labeling and packaging may differ, the medications themselves are the same. Oversight is provided by well-established regulatory bodies such as the FDA (U.S.), Health Canada, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (UK).

No. MedsDirectRx offers two options: a Domestic-Only Formulary and a Global Formulary. The Domestic Formulary sources medications exclusively within the U.S. The Global Formulary Includes international sourcing to maximize savings on high-cost prescriptions. You can choose the option that best fits your organization’s needs and comfort level.

The MedsDirectRx Domestic 340B Program is part of the U.S. federal 340B Drug Pricing Program, established in 1992 under Section 340B of the Public Health Service Act. This program allows eligible hospitals and clinics to purchase outpatient medications at significantly reduced prices, helping them stretch resources to better serve uninsured and low-income patients.

To participate through MedsDirectRx, individuals must:

  • Complete a brief eligibility questionnaire.
  • Schedule and attend a telehealth visit with a provider affiliated with the 340B-covered entity.
  • Once approved, they can begin receiving discounted medications through the program.

PRICING Request Form

Medication Information

Pricing Scope

Partner Information

This form is intended for general inquiries only and is not a secure channel for transmitting protected health information (PHI) under HIPAA.

A blue caduceus symbol next to the words HIPAA Compliant on a light gray background, representing adherence to health information privacy standards.